StreetInsider.com News Articles

Form 4 Sanara MedTech Inc. For: May 15 Filed by: Yon Seth D

Mon, 18 May 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260518/26513587.html

Form 4 Sanara MedTech Inc. For: May 15 Filed by: Yon Seth D

Mon, 18 May 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260518/26513587.html

Form 10-Q Sanara MedTech Inc. For: Mar 31

Tue, 12 May 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260512/26477512.html

Form 10-Q Sanara MedTech Inc. For: Mar 31

Tue, 12 May 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260512/26477512.html

Form 8-K Sanara MedTech Inc. For: May 11

Mon, 11 May 2026 17:22:00 -0400

si-local-file:///var/storage/secattach/20260511/26470673.html

Form 8-K Sanara MedTech Inc. For: May 11

Mon, 11 May 2026 17:22:00 -0400

si-local-file:///var/storage/secattach/20260511/26470673.html

Sanara MedTech Inc. (SMTI) Tops Q1 EPS by 8c

Mon, 11 May 2026 17:12:06 -0400

Sanara MedTech Inc. (NASDAQ: SMTI) reported Q1 EPS of $0.04, $0.08 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $27.8 million versus the consensus estimate of $26.9 million.

For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.

Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)

Mon, 11 May 2026 16:50:00 -0400

Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter

FORT WORTH, TX, May 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported its financial results for the first quarter ended March 31, 2026.

First Quarter 2026 Financial Summary⁽¹⁾

Net revenue increased 19% to $27.8 million,

Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)

Mon, 11 May 2026 16:50:00 -0400

Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter

First Quarter 2026 Financial Summary⁽¹⁾

Net revenue increased 19% to $27.8 million,

Form 4/A Sanara MedTech Inc. For: Mar 22 Filed by: Mackey Ashley M

Tue, 05 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260505/26434509.html

Form 4/A Sanara MedTech Inc. For: Mar 22 Filed by: Mackey Ashley M

Tue, 05 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260505/26434509.html

Form DEFA14A Sanara MedTech Inc.

Fri, 17 Apr 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260417/26330598.html

Form DEFA14A Sanara MedTech Inc.

Fri, 17 Apr 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260417/26330598.html

Form ARS Sanara MedTech Inc. For: Dec 31

Fri, 17 Apr 2026 07:41:00 -0400

si-local-file:///var/storage/secattach/20260417/26327728.html

Form ARS Sanara MedTech Inc. For: Dec 31

Fri, 17 Apr 2026 07:41:00 -0400

si-local-file:///var/storage/secattach/20260417/26327728.html

Form DEFA14A Sanara MedTech Inc.

Fri, 17 Apr 2026 07:35:00 -0400

si-local-file:///var/storage/secattach/20260417/26327717.html

Form DEFA14A Sanara MedTech Inc.

Fri, 17 Apr 2026 07:35:00 -0400

si-local-file:///var/storage/secattach/20260417/26327717.html

Form DEF 14A Sanara MedTech Inc. For: Dec 31

Fri, 17 Apr 2026 07:31:00 -0400

si-local-file:///var/storage/secattach/20260417/26327688.html

Form DEF 14A Sanara MedTech Inc. For: Dec 31

Fri, 17 Apr 2026 07:31:00 -0400

si-local-file:///var/storage/secattach/20260417/26327688.html

Form 4 Sanara MedTech Inc. For: Apr 15 Filed by: Waldrop Jacob A.

Thu, 16 Apr 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260416/26324932.html

Form 4 Sanara MedTech Inc. For: Apr 15 Filed by: Waldrop Jacob A.

Thu, 16 Apr 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260416/26324932.html

Lake Street Starts Sanara MedTech (SMTI) at Buy

Wed, 15 Apr 2026 08:08:22 -0400

Lake Street analyst Frank Takkinen initiates coverage on Sanara MedTech (NASDAQ: SMTI) with a Buy rating and a price target of $32.00.

For an analyst ratings summary and ratings history on Sanara MedTech click here. For more ratings news on Sanara MedTech click here.

Shares of Sanara MedTech closed at $18.51 yesterday.

Form SCHEDULE 13G/A Sanara MedTech Inc. Filed by: BAIRD TRUST Co

Tue, 14 Apr 2026 14:27:00 -0400

si-local-file:///var/storage/secattach/20260414/26311426.html

Form SCHEDULE 13G/A Sanara MedTech Inc. Filed by: BAIRD TRUST Co

Tue, 14 Apr 2026 14:27:00 -0400

si-local-file:///var/storage/secattach/20260414/26311426.html

Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026

Tue, 14 Apr 2026 07:30:00 -0400

FORT WORTH, TX, April 14, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company”, “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, announced today that it will report its first quarter 2026 financial results on Tuesday, May 12, 2026 before the U.S. financial markets open.

The Company will host a conference call and webcast on May 12, 2026 at 8:00 a.m. Eastern Time to discuss the results of the quarter ended March 31,